Drug maker Jubilant Organosys today said it has earmarked Rs 250 crore for its capacity expansion plans in the current fiscal.
"We are going to spend Rs 250 crore for capacity expansion. A majority of it would be spent on de-bottlenecking activities while a small portion of it would go for the R&D activities," Jubilant Organosys Chairman and Managing Director Shyam S Bhartia told reporters on the sidelines of World Economic Forum .
When asked about the company's proposed resolution to raise Rs 500 crore, he said it is only a "enabling" resolution and the time limit for the same has not been decided, adding that the resolution is for a one-year period.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app